The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Strange that a certain poster didn't bother to congratulate the team on its wonderful progress. The cynical out there would be led to believe that they are not in fact a shareholder here.
the sars virus came from china. that is a fact. glens silly comment is a bit like saying that if you claim that spaghetti comes from italy , that you are ******. keep the red flag flying glen.
It certainly is Ria. We all know that the next viral outbreak from China that far away.
"I’m still hoping for that £1 party we’ve talked about for so long now"
Tick,Tick Tock.
Worth re posting Brightys info from yesterday
In answer to your question, the likely candidates to gatecrash the party with an acquisition of part or all of HEMO would be:
* AZ: It has a track record of paying billions for smaller innovative pharma companies. e.g. it acquired CinCor Pharma for $1.8 Billion and paid $1 billion for KYM Bio and $2 Billion to partner Quell Therapeutics.
* Eli Lilly: HEMO have already had dealings with them in the past. They acquired Versanis for $1.925 billion.
* GSK: It needs to replenish its patent pipeline. They could be on the hunt for HEMO. They recently paid $1.4 Billion for Aiolos Bio and also acquired Affinivax for $ 2.10Billion. They also paid £1.6Billion to buy Bellus.
* Thermo Fisher: They acquired PeproTech for $1.85 Billion.
* Pfizer: They paid £6.7 Billion to buy Arena.
* Sanoffi: They have been pipped to the post on 2 deals recently. i.e. Biogen's $7.3 billion acquisition of Reata Pharmaceuticals. They also lost out on buying Horizon Therapeutics to Amgen who paid a massive $27.8 billion.
First things first, though. A licencing deal is the next most likely deal to come HEMO's way. The average licencing deal in our sector in the last 12 months was $47 Million.....
Good luck,Brighty
Brighty1
Posted in: HEMO
Posts: 2,443
Price: 3.375
No Opinion
RE: Thoughts13 Feb 2024 07:25
Prevail are onboard with HEMO for a reason. i.e. to hopefully secure a lucrative and long term licencing deal. The alternative to this could be that a major global player has gate crashed the party and has offered an even bigger licencing deal? That's how big pharma operate. Afterall, the R&D departments at the big companies will have been fully aware of the FDA application and process. Perhaps, they have been waiting for the FDA sign off before pouncing?
Anyway, lets get back to the bigger picture rather than cryptic tweets. The big opportunity for HEMO now that we are a P1 clinical company is that most license deals by big pharma happen at platform and discovery stages. That is HEMO now.
Some of the licencing deals over the last 12 months, below, have been mouth watering. Could HEMO be next?
* Akeso paid $500 million upfront by Summit Therapeutics in 2023 to in-license ivonescimab. Additionally, the partnership outlines a potential deal value of up to USD 4.5 billion.
* Alnylam received an upfront cash payment of USD 310 million from Roche in 2023 to co-develop and co-commercialize Zilebesiran. Additional development, regulatory, and sales milestones could potentially elevate the deal value to USD 2.8 billion.
* Evotec paid $50 Million upfront in 2023 by Bristol Myers Squibb. Tiered royalties on product sales further underscore the financial commitment, resulting in USD 4bn potential deal value.
* Kelun-Biotech paid an upfront $175 Million by Merck in 2023 to co-develop preclinical antibody-drug conjugates. Future development, regulatory, and sales milestone payments,
You can only hold a good guy down for so long.
Thank you Mornington. I think its about time this BB really got behind the company and the truly amazing work it is doing.
Big Pharma, with Big Pockets, will be Chomping at the bit to get a piece of HEMO. Next RNS will ANNOUNCE an amazing JV , money upfront (more than enough to complete CAR-T ) and a gigantic earn in potential. SP will go vertical.
I dont think that i have ever seen a small Pharma , with such a small Market Cap and so much potential . Very soon you are going to see a vertical line up on the HEMO SP graph.
This is Ground breaking and game changing. The route map to the £ 1 mark has now been re established. Once again, thanks to the team. Luckily they are working and creating ground breaking science, rather than listening to the moaners and wingers on here, who claim to talk the truth. The future is bright, the future IS HEMO.
PizzaGate.
" this board is the company's worst enemy." I have unfortunately arrived at the same conclusion.
Buying Mr. Gin, Buying.
The price will certainly rise when the news comes in , but All this talk about a discounted funding from the BB will probably make it drop even more in the short term. Unbelievable.
Mjing, when was the last time you bought hemo. :
Ignore these idiots mate - as you say they just turn up and sprout crap, always the same, the board will calm down in a bit and we can have some normality back again.
Where is your insight to HEMOs massive upside in your posts ?
Ming, you have failed to discuss Hemo m, ON ALL OF YOUR POSTS , please explain ?
Hemo,i think that is what your Wife said to you. Violence against women is totally unacceptable. I have suffered from it for many years from Men like you,
Watch HemoNoTruth slide way and disappear for a while.
More to the point, where is the 50p. Are you denying it ? . This is going to be funny.